D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Replimune Group
REPL
$1.23B
| $8.15M | 0.01% |
997,786
+754,780
| +311% | +$6.19M |
|
|
SKX
1402
DELISTED
Skechers
SKX
| $8.15M | 0.01% |
133,004
-171,568
| -56% | -$10.5M |
|
1403
CALL
TFI International
TFII
$10.3B
| $8.14M | 0.01% |
51,000
+9,000
| +21% | +$1.29M |
|
1404
CALL
TransDigm Group
TDG
$60B
| $8.13M | 0.01% |
6,600
| – | – |
|
1405
PUT
Darling Ingredients
DAR
$10.3B
| $8.1M | 0.01% |
174,200
+136,200
| +358% | +$6M |
|
1406
CALL
US Bancorp
USB
$93.6B
| $8.1M | 0.01% |
181,200
-148,800
| -45% | -$6.28M |
|
|
NETD
1407
DELISTED
Nabors Energy Transition Corp II
NETD
| $8.1M | 0.01% |
778,728
| – | – |
|
1408
CSX Corp
CSX
$87.3B
| $8.09M | 0.01% |
218,207
+111,918
| +105% | +$4.08M |
|
1409
CALL
Thomson Reuters
TRI
$40.9B
| $8.08M | 0.01% |
51,118
-25,520
| -33% | -$3.97M |
|
1410
Editas Medicine
EDIT
$415M
| $8.08M | 0.01% |
1,089,240
-98,324
| -8% | -$817K |
|
1411
Coursera
COUR
$1.33B
| $8.06M | 0.01% |
574,874
-330,501
| -37% | -$5.61M |
|
1412
MACOM Technology Solutions
MTSI
$21.1B
| $8.05M | 0.01% |
84,192
-105,012
| -56% | -$9.28M |
|
|
AAN
1413
DELISTED
The Aaron's Company Inc
AAN
| $8.03M | 0.01% |
1,071,302
-16,906
| -2% | -$158K |
|
1414
Cellebrite
CLBT
$2.92B
| $8.03M | 0.01% |
725,146
+254,038
| +54% | +$2.59M |
|
|
CFLT
1415
PUT
DELISTED
Confluent
CFLT
| $8.02M | 0.01% |
+262,900
| New | +$7.42M |
|
1416
Aurora
AUR
$12.6B
| $8.02M | 0.01% |
2,844,422
-254,893
| -8% | -$731K |
|
1417
PUT
Intuitive Surgical
ISRG
$139B
| $7.98M | 0.01% |
20,000
-30,000
| -60% | -$11.3M |
|
1418
CVS Health
CVS
$114B
| $7.97M | 0.01% |
99,919
-27,822
| -22% | -$2.13M |
|
|
DCPH
1419
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.97M | 0.01% |
506,384
+117,721
| +30% | +$1.81M |
|
1420
Bentley Systems
BSY
$9.84B
| $7.96M | 0.01% |
152,454
+136,840
| +876% | +$6.89M |
|
1421
RTX Corp
RTX
$261B
| $7.94M | 0.01% |
81,393
-22,407
| -22% | -$2.02M |
|
1422
CALL
Live Nation Entertainment
LYV
$38.9B
| $7.93M | 0.01% |
75,000
-40,000
| -35% | -$3.78M |
|
1423
Interactive Brokers
IBKR
$41.1B
| $7.93M | 0.01% |
283,820
-199,120
| -41% | -$4.96M |
|
1424
Mettler-Toledo International
MTD
$27.9B
| $7.92M | 0.01% |
5,948
-3,014
| -34% | -$3.72M |
|
1425
HubSpot
HUBS
$10.8B
| $7.9M | 0.01% |
12,603
-23,942
| -66% | -$14.4M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.